Literature DB >> 16612197

Schizophrenia and bipolar disorder: differences and overlaps.

Wolfgang Maier1, Astrid Zobel, Michael Wagner.   

Abstract

PURPOSE OF REVIEW: Following the recent progress mainly in the fields of genetics and neurobiology, the validity of the diagnostic distinction between schizophrenia and bipolar disorder is increasingly challenged. RECENT
FINDINGS: Evidence for basic neurobiological processes common for both disorders is expanding with regard to (a) susceptibility genes, (b) neurodevelopment (for example myelination), and (c) brain functions (for example sensory gating, visuospatial achievement). Recent epidemiological studies also stress communalities.
SUMMARY: The diagnostic split between schizophrenia and bipolar disorder is unable to define distinct etiological and/or pathophysiological entities.

Entities:  

Mesh:

Year:  2006        PMID: 16612197     DOI: 10.1097/01.yco.0000214342.52249.82

Source DB:  PubMed          Journal:  Curr Opin Psychiatry        ISSN: 0951-7367            Impact factor:   4.741


  40 in total

Review 1.  [Advances in neurobiological understanding of schizophrenia. Perspectives for new therapeutic concepts].

Authors:  P Falkai; W Maier
Journal:  Nervenarzt       Date:  2006-11       Impact factor: 1.214

Review 2.  Diagnostic validity of sensory over-responsivity: a review of the literature and case reports.

Authors:  Stacey Reynolds; Shelly J Lane
Journal:  J Autism Dev Disord       Date:  2007-10-05

3.  Chromosome 13q13-q14 locus overlaps mood and psychotic disorders: the relevance for redefining phenotype.

Authors:  Michel Maziade; Yvon C Chagnon; Marc-André Roy; Alexandre Bureau; Alain Fournier; Chantal Mérette
Journal:  Eur J Hum Genet       Date:  2009-01-28       Impact factor: 4.246

4.  ZNF804A Genetic Variation Confers Risk to Bipolar Disorder.

Authors:  Chen Zhang; Zuowei Wang; Wu Hong; Zhiguo Wu; Daihui Peng; Yiru Fang
Journal:  Mol Neurobiol       Date:  2015-05-03       Impact factor: 5.590

5.  Analysis of protocadherin alpha gene enhancer polymorphism in bipolar disorder and schizophrenia.

Authors:  Erika Pedrosa; Radu Stefanescu; Benjamin Margolis; Oriana Petruolo; Yungtai Lo; Karen Nolan; Tomas Novak; Pavla Stopkova; Herbert M Lachman
Journal:  Schizophr Res       Date:  2008-05-27       Impact factor: 4.939

6.  Serine enantiomers as diagnostic biomarkers for schizophrenia and bipolar disorder.

Authors:  Kenji Hashimoto
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2015-05-12       Impact factor: 5.270

7.  ERBB4 polymorphism and family history of psychiatric disorders on age-related cortical changes in healthy children.

Authors:  Vanessa Douet; Linda Chang; Kristin Lee; Thomas Ernst
Journal:  Brain Imaging Behav       Date:  2015-03       Impact factor: 3.978

8.  Genetic variants in the ErbB4 gene are associated with white matter integrity.

Authors:  Riccardo Zuliani; T William J Moorhead; Mark E Bastin; Eve C Johnstone; Stephen M Lawrie; Paolo Brambilla; Michael C O'Donovan; Michael J Owen; Jeremy Hall; Andrew M McIntosh
Journal:  Psychiatry Res       Date:  2011-01-12       Impact factor: 3.222

9.  Frontonasal dysmorphology in bipolar disorder by 3D laser surface imaging and geometric morphometrics: comparisons with schizophrenia.

Authors:  Robin J Hennessy; Patrizia A Baldwin; David J Browne; Anthony Kinsella; John L Waddington
Journal:  Schizophr Res       Date:  2010-05-31       Impact factor: 4.939

10.  Transcription factor SP4 is a susceptibility gene for bipolar disorder.

Authors:  Xianjin Zhou; Wei Tang; Tiffany A Greenwood; Shengzhen Guo; Lin He; Mark A Geyer; John R Kelsoe
Journal:  PLoS One       Date:  2009-04-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.